Pink Sheet Podcast: New US FDA Developments In AI Regulation

 
• By Pink Sheet Team

Pink Sheet reporter and editors discuss new developments in the FDA’s plans to regulate artificial intelligence and drugs associated with it, including a new AI Council within CDER, as well as some of the unanswered questions about AI in drug development.

Pink Sheet podcast
How will the work of CDER's AI Council get to the FDA's rank-and-file review staff? • Source: Citeline/Shutterstock

More from AI

More from Advanced Technologies